IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis

Clinical Immunology

Volumn 126, Issue 2, 2008, Pages 202-210

  Wu, Bo ^a   Huang, Chunhong ^a   Kato Maeda, Midori ^b   Hopewell, Philip C ^b   Daley, Charles L ^b,c   Krensky, Alan M ^a   Clayberger, Carol ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Cytokines; ; Dendritic cell; ; Human; Mycobacterium tuberculosis;

Indexed keywords

CYTOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 9; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFECTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TH1 CELL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-9; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TUBERCULOSIS;

EID: 37849013225     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.09.009     Document Type: Article

References (39)

1. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., and Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. (2003) 1009-1021
2. Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat. Med. 6 (2000) 955-960
3. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20 (2002) 581-620
4. Kampmann B., Hemingway C., Stephens A., Davidson R., Goodsall A., Anderson S., Nicol M., Scholvinck E., Relman D., Waddell S., Langford P., Sheehan B., Semple L., Wilkinson K.A., Wilkinson R.J., Ress S., Hibberd M., and Levin M. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J. Clin. Invest. 115 (2005) 2480-2488
5. Guyot-Revol V., Innes J.A., Hackforth S., Hinks T., and Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173 (2006) 803-810
6. Frucht D.M., and Holland S.M. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157 (1996) 411-416
7. Lai C.K., Ho S., Chan C.H., Chan J., Choy D., Leung R., and Lai K.N. Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis. Chest 111 (1997) 606-611
8. Lin Y., Zhang M., Hofman F.M., Gong J., and Barnes P.F. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64 (1996) 1351-1356
9. Sanchez F.O., Rodriguez J.I., Agudelo G., and Garcia L.F. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62 (1994) 5673-5678
10. Surcel H.M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., and Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81 (1994) 171-176
11. van Crevel R., Ottenhoff T.H., and van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15 (2002) 294-309
12. Wu B., Huang C., Kato-Maeda M., Hopewell P.C., Daley C.L., Krensky A.M., and Clayberger C. Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J. Immunol. 178 (2007) 3688-3694
13. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 161 (2000) 1376-1395
14. Doherty T.M., Demissie A., Menzies D., Andersen P., Rook G., and Zumla A. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J. Immunol. Methods 298 (2005) 129-141
15. Listvanova S., Temmerman S., Stordeur P., Verscheure V., Place S., Zhou L., Locht C., and Mascart F. Optimal kinetics for quantification of antigen-induced cytokines in human peripheral blood mononuclear cells by real-time PCR and by ELISA. J. Immunol. Methods 281 (2003) 27-35
16. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
17. de Jong E.C., Smits H.H., and Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26 (2005) 289-307
18. Spellberg B., and Edwards Jr. J.E. Type 1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 32 (2001) 76-102
19. North R.J., and Jung Y.J. Immunity to tuberculosis. Annu. Rev. Immunol. 22 (2004) 599-623
20. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
21. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., and Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183 (1996) 147-157
22. King I.L., and Segal B.M. Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J. Immunol. 175 (2005) 641-645
23. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., Ghilardi N., Desauvage F., and Cooper A.M. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-{gamma} responses if IL-12p70 is available. J. Immunol. 175 (2005) 788-795
24. Tato C.M., and O'Shea J.J. Immunology: what does it mean to be just 17?. Nature 441 (2006) 166-168
25. Jankovic D., Kullberg M.C., Caspar P., and Sher A. Parasite-induced Th2 polarization is associated with down-regulated dendritic cell responsiveness to Th1 stimuli and a transient delay in T lymphocyte cycling. J. Immunol. 173 (2004) 2419-2427
26. Marchant A., Amedei A., Azzurri A., Vekemans J., Benagiano M., Tamburini C., Lienhardt C., Corrah T., McAdam K.P., Romagnani S., D'Elios M.M., and Del Prete G. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am. J. Respir. Cell Mol. Biol. 24 (2001) 187-194
27. Demissie A., Abebe M., Aseffa A., Rook G., Fletcher H., Zumla A., Weldingh K., Brock I., Andersen P., and Doherty T.M. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J. Immunol. 172 (2004) 6938-6943
28. Seah G.T., Scott G.M., and Rook G.A. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 181 (2000) 385-389
29. Seah G.T., and Rook G.A. High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels. Scand. J. Infect. Dis. 33 (2001) 106-109
30. Poulin L.F., Habran C., Stordeur P., Goldman M., McKenzie A., Van Snick J., Renauld J.C., and Braun M.Y. Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells. Eur. Cytokine Netw. 16 (2005) 233-239
31. Houssiau F.A., Renauld J.C., Fibbe W.E., and Van Snick J. IL-2 dependence of IL-9 expression in human T lymphocytes. J. Immunol. 148 (1992) 3147-3151
32. Pilette C., Ouadrhiri Y., Van Snick J., Renauld J.C., Staquet P., Vaerman J.P., and Sibille Y. IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. J. Immunol. 168 (2002) 4103-4111
33. Soler D., Chapman T.R., Poisson L.R., Wang L., Cote-Sierra J., Ryan M., McDonald A., Badola S., Fedyk E., Coyle A.J., Hodge M.R., and Kolbeck R. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J. Immunol. 177 (2006) 6940-6951
34. Cosmi L., Liotta F., Angeli R., Mazzinghi B., Santarlasci V., Manetti R., Lasagni L., Vanini V., Romagnani P., Maggi E., Annunziato F., and Romagnani S. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103 (2004) 3117-3121
35. McKee A.S., and Pearce E.J. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173 (2004) 1224-1231
36. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
37. Knoops L., and Renauld J.C. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22 (2004) 207-215
38. Liu Y., Teige I., Birnir B., and Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12 (2006) 518-525
39. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., Strom T.B., Zheng X.X., and Noelle R.J. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002